KOREA PHARMA Co., Ltd.

A032300

KR7032300006

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-30 pm EDT			5-day change	1st Jan Change
17,760 ^KRW	+0.06%		-5.98%	-24.90%

May. 28	NetScientific backs Wanda; Inspirit Energy wins deal	AN
May. 28	Korea Pharma Co., Ltd Submits A New Drug Application to the Korean Ministry of Food and Drug Safety for the Review and Approval of Accrufer to Treat Patients with Iron Deficiency Anaemia in Korea	CI

KOREA PHARMA Co., Ltd.(KOSDAQ:A032300) dropped from S&P Global BMI Index

September 18, 2023 at 12:00 am EDT

Latest news about KOREA PHARMA Co., Ltd.

NetScientific backs Wanda; Inspirit Energy wins deal	May. 28	AN
Korea Pharma Co., Ltd Submits A New Drug Application to the Korean Ministry of Food and Drug Safety for the Review and Approval of Accrufer to Treat Patients with Iron Deficiency Anaemia in Korea	May. 28	CI
Astrogen Co.,Ltd. announced that it has received KRW 2.999998662 billion in funding from KOREA PHARMA Co., Ltd.	Nov. 29	CI
KOREA PHARMA Co., Ltd. announced that it has received KRW 23 billion in funding from Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., EBEST Investment & Securities Co., Ltd.	Nov. 27	CI
KOREA PHARMA Co., Ltd. announced that it expects to receive KRW 23 billion in funding from Samsung Securities Co., Ltd., KB Securities Co., Ltd., NH Investment & Securities Co., Ltd., Mirae Asset Securities Co., Ltd., EBEST Investment & Securities Co., Ltd. and others	Nov. 23	CI
Astrogen Co.,Ltd. announced that it expects to receive KRW 2.999998662 billion in funding from KOREA PHARMA Co., Ltd.	Nov. 13	CI
KOREA PHARMA Co., Ltd.(KOSDAQ:A032300) dropped from S&P Global BMI Index	23-09-18	CI
KOREA PHARMA Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
KOREA PHARMA Co., Ltd. announced that it has received KRW 50 billion in funding	21-10-25	CI
KOREA PHARMA Co., Ltd. announced that it expects to receive KRW 50 billion in funding	21-10-21	CI
KOREA PHARMA Co., Ltd.(KOSDAQ:A032300) added to S&P Global BMI Index	21-09-20	CI
KOREA PHARMA Co., Ltd. has completed an IPO in the amount of KRW 29.187 billion.	20-08-04	CI
KOREA PHARMA Co., Ltd. has filed an IPO.	20-04-13	CI

Korea Pharma Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of medicinal products. The Company's main products include digestive system solvents, antidepressants, blood circulation agents, antidementia drugs, schizophrenia medicines and others.

Sector

Pharmaceuticals

Calendar

2024-08-08 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
KOREA PHARMA CO., LTD.	-24.90%	140M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
NOVARTIS AG	+9.78%	210B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B

Other Pharmaceuticals

KOREA PHARMA Co., Ltd.

Equities

A032300

KR7032300006

Pharmaceuticals

KOREA PHARMA Co., Ltd.(KOSDAQ:A032300) dropped from S&P Global BMI Index

Latest news about KOREA PHARMA Co., Ltd.

Chart KOREA PHARMA Co., Ltd.

Company Profile

Income Statement Evolution

Chiffre d''affaires - Rate of surprise

Sector Other Pharmaceuticals